Clinical Trials Browser

Withdrawn × Interventional × Hepatoblastoma × Clear all

NCT04093648 2020-05-20

T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)

Phase 1 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma

NCT02011126 2018-08-07

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Phase 2 Withdrawn

CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00624962 2014-12-11

Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors

Phase NA Withdrawn

CNSGastrointestinalGenitourinaryOther hematologic neoplasmSarcoma

Familial ependymoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Medulloblastoma, Meningioma, Wilms Tumor, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma

NCT00228683 2013-11-26

Hepatoblastoma Biology Study and Tissue Bank

Phase NA Withdrawn

Gastrointestinal

Hepatoblastoma